Yahoo Web Search

Search results

  1. Chan Shen, PhD. Professor, Department of Surgery. Associate Professor, Department of Surgery. Chief, Division of Outcomes, Research and Quality. Scientific Program: Cancer Control. CZS5992@psu.edu. Research Interests. View Details. Therapeutics. Neoplasms. Medicare. Survival. Elderly. Breast Neoplasms. Costs and Cost Analysis. Neuroendocrine Tumors

    • Penn State

      Chan Shen, PhD. Professor, Department of Surgery. Chief,...

  2. Chan Shen, PhD. Professor, Department of Surgery. Chief, Division of Outcomes, Research and Quality. Penn State Cancer Institute. Cancer Institute, Cancer Control. h-index. 4632. Citations. 23. h-index. 2008 2024. Research activity per year. Overview. Fingerprint. Network. Grants & Projects (2) Research output (159) Personal profile.

  3. Dr Chan Wah Hak Nien-Shen Charles is a Cardiologist (Heart Specialist) at Charles Chan Heart Clinic Pte Ltd. Find more information about the clinic and book an appointment online.

  4. en.wikipedia.org › wiki › Chan_ShenChan Shen - Wikipedia

    Chan Shen (11 March 1940 - 26 April 1984) was a Taiwanese-born Hong Kong film actor. He is best known for his roles as gangsters or villains in Hong Kong action cinema in the 1970s. Already an established film actor in Taiwan, he entered the Hong Kong film industry in 1971.

  5. Nov 25, 2022 · RESEARCH ARTICLE. Open Access. Endocrine therapy initiation and overall survival outcomes with omission of radiation therapy in older Medicare patients with early-stage hormone-receptor-positive breast cancer. Chan Shen, Ning Li, Shouhao Zhou, Kelly Stahl, Daleela Dodge, Hui Zhao. First published: 25 November 2022.

  6. Chan Chun Sing (Chinese: 陈振声; pinyin: Chén Zhènshēng; born 9 October 1969) is a Singaporean politician and former major-general who has been serving as Minister for Education since 2021 and Minister-in-charge of Public Service since 2018.

  7. Endocrine therapy initiation and overall survival outcomes with omission of radiation therapy in older Medicare patients with early-stage hormone-receptor-positive breast cancer. Cancer Med. 2022 Nov 25. doi: 10.1002/cam4.5488. Online ahead of print.